Amy Soloman, DO
Gastroenterology · Avondale, AZNPI 1982723508
Payments from drug & device makers
Across 406 payments — averaging $824.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$151K
- AstraZeneca$55K
- E.r. Squibb & Sons, L.L.C.$55K
- Takeda Pharmaceuticals U.S.A., Inc.$36K
- AbbVie$18K
- Amgen$10K
- plus $9K from 30 others
Across 2 payments — averaging $16,812 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$34K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 12 | $151,072 |
| AstraZeneca | 12 | $55,463 |
| E.r. Squibb & Sons, L.L.C. | 4 | $55,314 |
| Takeda Pharmaceuticals U.S.A., Inc. | 61 | $35,906 |
| AbbVie(2 entities) | 78 | $17,751 |
| Amgen | 2 | $10,396 |
| Phathom Pharmaceuticals, Inc. | 22 | $5,227 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 95 | $1,136 |
| Sanofi | 23 | $544 |
| Johnson & Johnson | 16 | $414 |
| Bristol Myers Squibb | 19 | $350 |
| Ironwood Pharmaceuticals, Inc | 9 | $147 |
| Regeneron Healthcare Solutions, Inc. | 6 | $147 |
| Ardelyx, Inc. | 7 | $120 |
| Regeneron | 1 | $117 |
| Medtronic | 2 | $105 |
| Merck | 4 | $83 |
| Nestle Healthcare Nutrition Inc. | 4 | $83 |
| QOL Medical, LLC | 5 | $69 |
| Gilead | 4 | $62 |
| Intercept Pharmaceuticals, Inc. | 3 | $56 |
| Shire North American Group Inc | 2 | $36 |
| Ferring Pharmaceuticals Inc. | 2 | $27 |
| UCB, Inc. | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Lucid Diagnostics Inc. | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $21 |
| Novo Nordisk | 1 | $20 |
| Boehringer Ingelheim | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Braintree Laboratories, Inc. | 1 | $16 |
| W. L. Gore & Associates, Inc. | 1 | $15 |
| Shionogi Inc | 1 | $15 |
| Redhill Biopharma Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
| Intra-sana Laboratories | 1 | $8 |
How this compares
$334,853 in reported general payments places this provider in the 90th percentile of 355 gastroenterology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Avondale
- Joseph DavisChandler$7.4M
- Sam MoussaTucson$3.9M
- Manreet KaurScottsdale$2.5M
- Bassel KissoTucson$2.3M
- Fadi DeebTucson$1.5M
- Chirag TrivediSun City$954K
- Joel BrillParadise Valley$850K
- Daniel MelineScottsdale$795K
- Moises Nevah RubinPhoenix$763K
- Sasha TalebanTucson$744K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.